Vitamin—Conjugated Metallic Nanoparticles: Applications for Antimicrobial and Anti-Cancer Drug Delivery
Molecules · 2025
DOI: 10.3390/molecules30214248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Meriama Genamo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Arts and Sciences, Prairie View A&M University, Prairie View, TX 77446, USA. Hauptthemen laut MEDLINE: Metal Nanoparticles, Antineoplastic Agents, Vitamins, Anti-Infective Agents. Die Arbeit nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) Evans-Allen Grant, United States Department of Agriculture National Institute of Food and Agriculture.
Abstract (Originalsprache)
Vitamin-conjugated metallic nanoparticles (VC-MNPs) have emerged as a transformative platform in nanomedicine that combine the therapeutic potential of vitamins with the structural versatility of metal nanoparticles. They offer a dual advantage of targeted drug delivery and enhanced therapeutic efficacy, enabling precise intervention against infectious and malignant diseases. Vitamin conjugation facilitates receptor-mediated targeting, antioxidant enhancement, and improved biocompatibility, thereby strengthening therapeutic outcomes and reducing off-target effects. This review critically evaluates how vitamin functionalization modulates the synthesis, activity, and clinical translation of VC-MNPs. Diverse synthesis methods including chemical reduction, co-precipitation, sol–gel, and green approaches are evaluated, along with the influence of synthesis parameters on nanoparticle performance. The mechanisms underlying enhanced antimicrobial and anti-cancer efficacy are discussed, highlighting the contributions of vitamin functionalization to cellular uptake, redox balance and metabolic selectivity. Critical challenges in clinical translation are systematically assessed, including nanoparticle stability under physiological conditions, potential toxicity concerns, regulatory approval pathways, and manufacturing scalability requirements. Finally, the paper considers future perspectives, focusing on synthesis innovations, novel therapeutic targets, interdisciplinary collaborations, and pathways for clinical translation. Overall, VC-MNPs represent a promising next-generation platform for precision nanomedicine and sustainable therapeutic design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Arts and Sciences, Prairie View A&M University, Prairie View, TX 77446, USA.
- Cooperative Agriculture Research Center, College of Agriculture, Food and Natural Resources, Prairie View A&M University, MS 2008, P.O. Box 519, Prairie View, TX 77446, USA.
ORCID-Profile: Meriama Genamo, Addisie Geremew
Förderung
- United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) Evans-Allen Grant
- United States Department of Agriculture National Institute of Food and Agriculture
Zitieren
APA
Genamo, M., Geremew, A., Peace, E., & Carson, L. (2025). Vitamin—Conjugated Metallic Nanoparticles: Applications for Antimicrobial and Anti-Cancer Drug Delivery. Molecules. https://doi.org/10.3390/molecules30214248
Vancouver
Genamo M, Geremew A, Peace E, Carson L. Vitamin—Conjugated Metallic Nanoparticles: Applications for Antimicrobial and Anti-Cancer Drug Delivery. Molecules. 2025. doi:10.3390/molecules30214248
BibTeX
@article{Genamo2025,
author = {Genamo, Meriama and Geremew, Addisie and Peace, Elisha and Carson, Laura},
title = {Vitamin—Conjugated Metallic Nanoparticles: Applications for Antimicrobial and Anti-Cancer Drug Delivery},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30214248}
}
EUVIMED